Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer-Reference-Cited by-同舟云学术

Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer

Published:2020-08 Issue:5 Volume:32 Page:107994
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Vaishnavi Aria^ORCID,Scherzer Michael T.,Kinsey Conan G.,Parkman Gennie L.^ORCID,Truong Amanda^ORCID,Ghazi Phaedra^ORCID,Schuman Sophia,Battistone Benjamin^ORCID,Garrido-Laguna Ignacio,McMahon Martin

Funder

Five for The Fight

Huntsman Cancer Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. Cytokeratins and cell differentiation in the pancreas;Bouwens;J. Pathol.,1998

2. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival;Cartlidge;Pigment Cell Melanoma Res.,2008

3. Resistance to TRK inhibition mediated by convergent MAPK pathway activation;Cocco;Nat. Med.,2019

4. Tumour biology: senescence in premalignant tumours;Collado;Nature,2005

5. Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study;Day;Pigment Cell Melanoma Res.,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the peripheral neural-tumour microenvironment for cancer therapy;Nature Reviews Drug Discovery;2024-09-06

2. TRKing down drug resistance in NTRK fusion‐positive cancers^†;The Journal of Pathology;2024-07-29

3. Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model;The Journal of Pathology;2024-04-12

4. SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma;Molecular Oncology;2024-01-18

5. Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases;Frontiers in Oncology;2023-12-07